The hidden danger in Trump’s drug-price plan

make prescription drugs more affordable. But before adopting policies that could reduce investment in biotechnology, policymakers should pause long enough to complete Boyd’s “orient” step.

RELATED: Eli Lilly strikes a $3 billion Chinese drug deal

Nikos Pekiaridis/NurPhoto/Getty Images

In an era of growing strategic competition with China, protecting America’s continue reading …